PRA GROUP INC
For the period ended Jun 30, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
(Unaudited)
Note 1. Organization and Business
As used herein, the terms "PRA Group," the "Company," or similar terms refer to PRA Group, Inc. and its subsidiaries.
Nature of operations
PRA Group, Inc., a Delaware corporation headquartered in Norfolk, Virginia, is a global financial services company with operations in the Americas, Europe and Australia. The Company's primary business is the purchase, collection and management of portfolios of nonperforming loans. The Company also purchases and provides fee-based services for class action claims recoveries in the United States ("U.S.").
Basis of presentation
The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and the instructions for Quarterly Reports on Form 10-Q of the U.S. Securities and Exchange Commission ("SEC"). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal and recurring items, necessary for a fair presentation have been included. The unaudited Consolidated Financial Statements include the accounts of PRA Group and other entities in which the Company has a controlling interest. All significant intercompany accounts and transactions have been eliminated.
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed. Realized results could differ from those estimates and assumptions. These unaudited Consolidated Financial Statements may not be indicative of future results and should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Form 10-K").
Prior period reclassifications
In the Consolidated Statements of Cash Flows, certain prior period amounts have been reclassified for consistency with the current period presentation.
Note 2. Finance Receivables, net
Finance receivables, net consisted of the following as of June 30, 2025 and December 31, 2024 (in thousands):
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| Amortized cost | $— | $— |
| Negative allowance for expected recoveries | 4,562,576 | 4,140,742 |
| Balance as of end of period | $4,562,576 | $4,140,742 |
Changes in Finance receivables, net by portfolio type for the three and six months ended June 30, 2025 and 2024 were as follows (in thousands):
| Three Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Core | Insolvency | Total | Core | Insolvency | Total | |
| Balance as of beginning of period | $3,986,864 | $321,470 | $4,308,334 | $3,298,092 | $352,103 | $3,650,195 |
| Initial negative allowance for expected recoveries on current period purchases (1) | 319,562 | 26,943 | 346,505 | 326,752 | 52,617 | 379,369 |
| Recoveries collected and applied to Finance receivables, net (2) | (251,657) | (37,940) | (289,597) | (226,247) | (43,033) | (269,280) |
| Changes in expected recoveries (3) | 25,342 | 7,950 | 33,292 | 65,747 | 7,573 | 73,320 |
| Foreign currency translation adjustment | 154,158 | 9,884 | 164,042 | (13,623) | 205 | (13,418) |
| Balance as of end of period | $4,234,269 | $328,307 | $4,562,576 | $3,450,721 | $369,465 | $3,820,186 |
| Six Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Core | Insolvency | Total | Core | Insolvency | Total | |
| Balance as of beginning of period | $3,809,723 | $331,019 | $4,140,742 | $3,295,214 | $361,384 | $3,656,598 |
| Initial negative allowance for expected recoveries on current period purchases (1) | 593,455 | 44,752 | 638,207 | 545,409 | 79,777 | 625,186 |
| Recoveries collected and applied to Finance receivables, net (2) | (483,140) | (71,575) | (554,715) | (441,463) | (79,477) | (520,940) |
| Changes in expected recoveries (3) | 51,667 | 9,547 | 61,214 | 115,311 | 9,683 | 124,994 |
| Foreign currency translation adjustment | 262,564 | 14,564 | 277,128 | (63,750) | (1,902) | (65,652) |
| Balance as of end of period | $4,234,269 | $328,307 | $4,562,576 | $3,450,721 | $369,465 | $3,820,186 |
(1) Initial negative allowance for expected recoveries on current period purchases
The initial negative allowance for expected recoveries on current period purchases for the three and six months ended June 30, 2025 and 2024 was as follows (in thousands):
| Three Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Core | Insolvency | Total | Core | Insolvency | Total | |
| Allowance for credit losses at acquisition | $(1,635,702) | $(87,742) | $(1,723,444) | $(1,758,462) | $(203,614) | $(1,962,076) |
| Writeoffs, net | 1,635,702 | 87,742 | 1,723,444 | 1,758,462 | 203,614 | 1,962,076 |
| Expected recoveries | 319,562 | 26,943 | 346,505 | 326,752 | 52,617 | 379,369 |
| Initial negative allowance for expected recoveries on current period purchases | $319,562 | $26,943 | $346,505 | $326,752 | $52,617 | $379,369 |
| Six Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Core | Insolvency | Total | Core | Insolvency | Total | |
| Allowance for credit losses at acquisition | $(3,053,673) | $(161,334) | $(3,215,007) | $(3,017,051) | $(277,228) | $(3,294,279) |
| Writeoffs, net | 3,053,673 | 161,334 | 3,215,007 | 3,017,051 | 277,228 | 3,294,279 |
| Expected recoveries | 593,455 | 44,752 | 638,207 | 545,409 | 79,777 | 625,186 |
| Initial negative allowance for expected recoveries on current period purchases | $593,455 | $44,752 | $638,207 | $545,409 | $79,777 | $625,186 |
The purchase price on current period purchases for the three and six months ended June 30, 2025 and 2024 was as follows (in thousands):
| Three Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Core | Insolvency | Total | Core | Insolvency | Total | |
| Face value | $2,269,417 | $129,842 | $2,399,259 | $2,402,148 | $279,417 | $2,681,565 |
| Noncredit discount | (314,153) | (15,157) | (329,310) | (316,934) | (23,186) | (340,120) |
| Allowance for credit losses at acquisition | (1,635,702) | (87,742) | (1,723,444) | (1,758,462) | (203,614) | (1,962,076) |
| Purchase price | $319,562 | $26,943 | $346,505 | $326,752 | $52,617 | $379,369 |
| Six Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Core | Insolvency | Total | Core | Insolvency | Total | |
| Face value | $4,235,481 | $231,316 | $4,466,797 | $4,110,779 | $393,633 | $4,504,412 |
| Noncredit discount | (588,353) | (25,230) | (613,583) | (548,319) | (36,628) | (584,947) |
| Allowance for credit losses at acquisition | (3,053,673) | (161,334) | (3,215,007) | (3,017,051) | (277,228) | (3,294,279) |
| Purchase price | $593,455 | $44,752 | $638,207 | $545,409 | $79,777 | $625,186 |
(2) Recoveries collected and applied to Finance receivables, net
Recoveries collected and applied to Finance receivables, net for the three and six months ended June 30, 2025 and 2024 were as follows (in thousands):
| Three Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Core | Insolvency | Total | Core | Insolvency | Total | |
| Recoveries collected (a) | $491,074 | $49,457 | $540,531 | $423,659 | $54,911 | $478,570 |
| Amounts reclassified to portfolio income (b) | (239,417) | (11,517) | (250,934) | (197,412) | (11,878) | (209,290) |
| Recoveries collected and applied to Finance receivables, net | $251,657 | $37,940 | $289,597 | $226,247 | $43,033 | $269,280 |
| Six Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Core | Insolvency | Total | Core | Insolvency | Total | |
| Recoveries collected (a) | $952,043 | $94,564 | $1,046,607 | $829,972 | $102,314 | $932,286 |
| Amounts reclassified to portfolio income (b) | 468,903 | 22,989 | 491,892 | 388,509 | 22,837 | 411,346 |
| Recoveries collected and applied to Finance receivables, net | $483,140 | $71,575 | $554,715 | $441,463 | $79,477 | $520,940 |
(a)Includes cash collections, buybacks and other cash-based adjustments.
(b)Reclassifications from Finance receivables, net to Portfolio income based on the effective interest rate of the underlying account pools.
(3) Changes in expected recoveries
Changes in expected recoveries for the three months ended June 30, 2025 and 2024 were as follows (in thousands):
| Three Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Core | Insolvency | Total | Core | Insolvency | Total | |
| Recoveries collected in excess of forecast | $32,316 | $7,986 | $40,302 | $46,830 | $7,430 | $54,260 |
| Changes in expected future recoveries | (6,974) | (36) | (7,010) | 18,917 | 143 | 19,060 |
| Changes in expected recoveries | $25,342 | $7,950 | $33,292 | $65,747 | $7,573 | $73,320 |
Changes in expected recoveries for the three months ended June 30, 2025 were $33.3 million, which included $40.3 million in recoveries collected in excess of forecast (cash collections overperformance) and a $7.0 million negative adjustment in changes in expected future recoveries. Recoveries collected in excess of forecast were largely due to cash collections overperformance in Europe, U.S., and Brazil. Changes in expected future recoveries were primarily due to a decrease to the collections forecast on the 2023 U.S. Core pool, which was partially offset by the impact of increases to the Company's collections forecasts in Europe.
Changes in expected recoveries for the three months ended June 30, 2024 were $73.3 million, which included $54.3 million in recoveries collected in excess of forecast, due mainly to collections performance in the U.S., driven in large part by the Company's cash-generating initiatives, coupled with collections performance in Europe. Changes in expected future recoveries of $19.1 million mainly reflect the Company's assessment of certain pools in the U.S. and Europe, resulting in an increase to the expected cash flows based primarily on overperformance in recent periods. The increase in expected cash flows was driven in large part by forecast increases to the 2013 to 2019 U.S. Core pools, as well as increases to a number of pools in Europe.
Changes in expected recoveries for the six months ended June 30, 2025 and 2024 were as follows (in thousands):
| Six Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Core | Insolvency | Total | Core | Insolvency | Total | |
| Recoveries collected in excess of forecast | $46,606 | $10,196 | $56,802 | $80,748 | $9,350 | $90,098 |
| Changes in expected future recoveries | 5,061 | (649) | 4,412 | 34,563 | 333 | 34,896 |
| Changes in expected recoveries | $51,667 | $9,547 | $61,214 | $115,311 | $9,683 | $124,994 |
Changes in expected recoveries for the six months ended June 30, 2025 were $61.2 million, which included $56.8 million in recoveries collected in excess of forecast (cash collections overperformance) and $4.4 million in changes in expected future recoveries. Recoveries collected in excess of forecast were largely due to cash collections overperformance in Europe and Brazil. Changes in expected future recoveries were primarily due to the impact of increases to the Company's collections forecasts on certain European pools, which was partially offset by decreases to the Company's collections forecasts on the 2023 U.S. Core pool.
Changes in expected recoveries for the six months ended June 30, 2024 were $125.0 million, which included $90.1 million in recoveries received in excess of forecast, due mainly to collections performance in the U.S., driven in large part by the Company's cash-generating initiatives, coupled with collections performance in Brazil and Europe. Changes in expected future recoveries of $34.9 million mainly reflect the Company's assessment of certain pools in the U.S. and Europe, resulting in an increase to the expected cash flows based primarily on overperformance in recent periods. The increase in expected cash flows was driven in large part by forecast increases to the 2013 to 2019 U.S. Core pools, as well as increases to a number of pools in Europe.
Note 3. Investments
Investments consisted of the following as of June 30, 2025 and December 31, 2024 (in thousands):
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| Debt securities | ||
| Available-for-sale | $64,774 | $55,762 |
| Equity securities | ||
| Private equity funds | 1,726 | 1,848 |
| Equity method investment | — | 8,694 |
| Total investments | $66,500 | $66,304 |
Debt securities
As of June 30, 2025, the Company's debt securities consisted of Swedish treasury securities maturing within one year. As of June 30, 2025 and December 31, 2024, the amortized cost and fair value of these investments were as follows (in thousands):
| June 30, 2025 | December 31, 2024 | |||||
|---|---|---|---|---|---|---|
| Amortized Cost | Gross Unrealized Gains | Aggregate Fair Value | Amortized Cost | Gross Unrealized Gains | Aggregate Fair Value | |
| Debt securities | $64,600 | $174 | $64,774 | $55,556 | $206 | $55,762 |
Equity method investment
The Company's equity method investment of 11.7% interest in RCB Investimentos S.A. ("RCB"), a servicing company for nonperforming loans in Brazil, was sold in April 2025. The Company recorded a $38.4 million pretax gain on sale in its Consolidated Financial Statements for the three months ended June 30, 2025. The sale does not impact the Company's ownership of existing portfolio investments in Brazil, nor its existing operations or future portfolio investments in Brazil.
Note 4. Goodwill
Changes in goodwill for the three and six months ended June 30, 2025 and 2024, were as follows (in thousands):
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Balance as of beginning of period | $420,715 | $411,846 | $396,357 | $431,564 |
| Foreign currency translation | 18,734 | 3,800 | 43,092 | (15,918) |
| Balance as of end of period | $439,449 | $415,646 | $439,449 | $415,646 |
The Company performs an annual review of goodwill as of October 1 of each year, or more frequently if indicators of impairment exist. The Company evaluated whether any triggering events had occurred as of June 30, 2025, which included consideration of market conditions, and determined that an interim impairment test of goodwill did not need to be performed.
Note 5. Borrowings
Borrowings consisted of the following as of June 30, 2025 and December 31, 2024 (in thousands):
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| North American revolving credit facility (1) | $667,875 | $519,519 |
| North American term loan (2) | 465,111 | 470,111 |
| United Kingdom revolving credit facility (3) | 479,282 | 494,185 |
| European revolving credit facility (4) | 713,529 | 555,726 |
| Credit facility borrowings | 2,325,797 | 2,039,541 |
| 2028 senior notes | 398,000 | 398,000 |
| 2029 senior notes | 350,000 | 350,000 |
| 2030 senior notes | 550,000 | 550,000 |
| Senior notes | 1,298,000 | 1,298,000 |
| Credit facility borrowings and senior notes | 3,623,797 | 3,337,541 |
| Unamortized debt premium and issuance costs, net | (9,589) | (10,920) |
| Total borrowings | $3,614,208 | $3,326,621 |
(1)Revolving credit facility under the Company's North American credit agreement with a combined domestic and Canadian limit of $1.1 billion (subject to the borrowing base and debt covenants, including advance rates), maturing on October 28, 2029.
(2)Term loan under the Company's North American credit agreement, with a final maturity date of October 28, 2029.
(3)Revolving credit facility with a limit of $725.0 million (subject to the borrowing base and debt covenants, including advance rates), maturing on October 30, 2029.
(4)Revolving credit facility with an aggregate limit of approximately €730.0 million (subject to the borrowing base and debt covenants, including advance rates), maturing on November 23, 2027.
For additional information about the North American revolving credit facility and term loan, United Kingdom revolving credit facility, European revolving credit facility and the Company's senior notes, refer to Note 7 to the Consolidated Financial Statements in the 2024 Form 10-K.
On April 24, 2025, the European revolving credit facility was amended and restated; however, the terms have not changed substantially from the terms described in the 2024 Form 10-K.
The Company was in compliance with the covenants contained in its financing arrangements as of June 30, 2025.
Note 6. Derivatives
The Company periodically enters into interest rate swaps and foreign exchange contracts to reduce its exposure to fluctuations in interest rates on variable-rate debt and foreign currency exchange rates. The fair value of these instruments as of June 30, 2025 and December 31, 2024 was as follows (in thousands):
| June 30, 2025 | December 31, 2024 | |||
|---|---|---|---|---|
| Balance Sheet Location | Fair Value | Balance Sheet Location | Fair Value | |
| Designated as hedging instruments: | ||||
| Interest rate swaps | Other assets | $2,508 | Other assets | $8,514 |
| Interest rate swaps | Other liabilities | 10,904 | Other liabilities | 4,797 |
| Not designated as hedging instruments: | ||||
| Foreign exchange contracts | Other assets | 256 | Other assets | 2,209 |
| Foreign exchange contracts | Other liabilities | 3,167 | Other liabilities | 166 |
Derivatives designated as hedging instruments
The effects of interest rate swaps designated as cash flow hedging instruments for the three and six months ended June 30, 2025 and 2024 were as follows (in thousands):
| Gain/(loss) recognized in OCI, net of tax | ||||
|---|---|---|---|---|
| Three Months Ended June 30, | Six Months Ended June 30, | |||
| Hedging instrument | 2025 | 2024 | 2025 | 2024 |
| Interest rate swaps | $(4,086) | $2,860 | $(4,010) | $9,930 |
| Gain reclassified from OCI into income | ||||
| Three Months Ended June 30, · Six Months Ended June 30, | ||||
| Income statement location | 2025 | 2024 | 2025 | 2024 |
| Interest expense, net | $2,914 | $5,532 | $5,577 | $11,206 |
As of June 30, 2025 and December 31, 2024, the notional amount of outstanding interest rate swaps was$908.8 million and $800.7 million, respectively. These swaps remained highly effective as of June 30, 2025 and have remaining terms ranging from seven months tofive years. As of June 30, 2025, the amounts of derivative gains and losses included in other comprehensive income ("OCI") that are estimated to be reclassified into earnings within the next 12 months net to $0.
Derivatives not designated as hedging instruments
The effects of foreign exchange contracts not designated as hedging instruments for the three and six months ended June 30, 2025 and 2024 were as follows (in thousands):
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| Income statement location | 2025 | 2024 | 2025 | 2024 |
| Foreign exchange (loss)/gain, net | $(17,190) | $726 | $(15,696) | $826 |
| Interest expense, net | 150 | 117 | (1) | 309 |
As of June 30, 2025 and December 31, 2024, the notional amount of outstanding foreign exchange contracts was$477.6 million and$376.4 million, respectively.
Note 7. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety.
Financial instruments carried at fair value
As of June 30, 2025 and December 31, 2024, financial instruments measured at fair value on a recurring basis were as follows (in thousands):
| Quoted Prices in Active Markets (Level 1) | Other Observable Inputs (Level 2) | Unobservable Inputs (Level 3) | Total | |
|---|---|---|---|---|
| Assets | ||||
| Government securities | $64,774 | $— | $— | $64,774 |
| Derivatives (1) | — | 2,764 | — | 2,764 |
| Liabilities | ||||
| Derivatives (1) | — | 14,071 | — | 14,071 |
| Assets | ||||
| Government securities | $55,762 | $— | $— | $55,762 |
| Derivatives (1) | — | 10,723 | — | 10,723 |
| Liabilities | ||||
| Derivatives (1) | — | 4,963 | — | 4,963 |
(1)Fair value of derivatives is estimated using industry standard valuation models, which project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves and other factors.
Financial instruments not carried at fair value
As of June 30, 2025 and December 31, 2024, the estimated fair value and carrying amount of financial instruments not carried at fair value were as follows (in thousands):
| Estimated Fair Value | ||||
|---|---|---|---|---|
| Quoted Prices in Active Markets (Level 1) | Other Observable Inputs (Level 2) | Unobservable Inputs (Level 3) | Carrying Value | |
| Financial assets | ||||
| Cash and cash equivalents | $131,592 | $— | $— | $131,592 |
| Finance receivables, net (1) | — | — | 4,338,291 | 4,562,576 |
| Financial liabilities | ||||
| Interest-bearing deposits (2) | — | 168,656 | — | 168,656 |
| Revolving lines of credit (3) | — | 1,860,686 | — | 1,860,686 |
| Term loan (3) (5) | — | 465,111 | — | 465,111 |
| Senior notes (4) (5) | — | 1,303,947 | — | 1,298,000 |
| Financial assets | ||||
| Cash and cash equivalents | $105,938 | $— | $— | $105,938 |
| Finance receivables, net (1) | — | — | 3,523,949 | 4,140,742 |
| Financial liabilities | ||||
| Interest-bearing deposits (2) | — | 163,406 | — | 163,406 |
| Revolving lines of credit (3) | — | 1,569,430 | — | 1,569,430 |
| Term loan (3) (5) | — | 470,111 | — | 470,111 |
| Senior notes (4) (5) | — | 1,301,244 | — | 1,298,000 |
(1)Fair value is estimated using the proprietary pricing models the Company utilizes to make portfolio acquisition decisions.
(2)Fair value is based on quoted prices for similar instruments in active markets and approximates carrying value due to the short-term deposit periods.
(3)Fair value is based on quoted prices for similar instruments in active markets and approximates carrying value due to the short-term interest rate periods.
(4)Fair value is based on quoted market prices obtained from secondary market broker quotes.
(5)The carrying amounts and fair values do not include debt issuance costs.
Note 8. Accumulated Other Comprehensive Income/Loss
Reclassifications out of Accumulated other comprehensive loss for the three and six months ended June 30, 2025 and 2024, were as follows (in thousands):
| Three Months Ended June 30, · Six Months Ended June 30, | |||||
|---|---|---|---|---|---|
| Cash flow hedges | Income Statement location | 2025 | 2024 | 2025 | 2024 |
| Interest rate swaps | Interest expense, net | $2,914 | $5,532 | $5,577 | $11,206 |
| Income tax effect (1) | Income tax expense | (703) | (1,378) | (1,348) | (2,790) |
| Total gain on cash flow hedges | $2,211 | $4,154 | $4,229 | $8,416 | |
(1)Income tax effects are released from Accumulated other comprehensive loss contemporaneously with the related gross pretax amount.
Changes in Accumulated other comprehensive loss by component, after tax, for the three and six months ended June 30, 2025 and 2024, were as follows (in thousands):
| Three Months Ended June 30, | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||||
| Debt Securities | Cash | Currency | Accumulated | Debt Securities | Cash | Currency | Accumulated | |
| Available-for-sale | Flow Hedges | Translation Adjustments | Other Comp. Loss | Available-for-sale | Flow Hedges | Translation Adjustments | Other Comp. Loss (1) | |
| Balance as of beginning of period | $24 | $169 | $(365,106) | $(364,913) | $111 | $9,405 | $(382,534) | $(373,018) |
| Other comprehensive gain/(loss) before reclassifications | 148 | (4,086) | 87,328 | 83,390 | 65 | 2,861 | (7,563) | (4,637) |
| Reclassifications, net | — | (2,211) | — | (2,211) | — | (4,154) | — | (4,154) |
| Net current period other comprehensive gain/(loss) | 148 | (6,297) | 87,328 | 81,179 | 65 | (1,293) | (7,563) | (8,791) |
| Balance as of end of period | $172 | $(6,128) | $(277,778) | $(283,734) | $176 | $8,112 | $(390,097) | $(381,809) |
(1)Net of deferred taxes for unrealized (gains)/losses from cash flow hedges of $(2.0) million and $0.4 million for the three months ended June 30, 2025 and 2024, respectively
| Six Months Ended June 30, | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||||
| Debt Securities | Cash | Currency | Accumulated | Debt Securities | Cash | Currency | Accumulated | |
| Available-for-sale | Flow Hedges | Translation Adjustments | Other Comp. Loss (1) | Available-for-sale | Flow Hedges | Translation Adjustments | Other Comp. Loss (1) | |
| Balance at beginning of period | $205 | $2,111 | $(445,710) | $(443,394) | $65 | $6,597 | $(336,561) | $(329,899) |
| Other comprehensive gain/(loss) before reclassifications | (33) | (4,010) | 167,932 | 163,889 | 111 | 9,931 | (53,536) | (43,494) |
| Reclassifications, net | — | (4,229) | — | (4,229) | — | (8,416) | — | (8,416) |
| Net current period other comprehensive gain/(loss) | (33) | (8,239) | 167,932 | 159,660 | 111 | 1,515 | (53,536) | (51,910) |
| Balance at end of period | $172 | $(6,128) | $(277,778) | $(283,734) | $176 | $8,112 | $(390,097) | $(381,809) |
(1)Net of deferred taxes for unrealized (gains)/losses from cash flow hedges $(2.0) million and $(2.7) million for the six months ended June 30, 2025 and 2024, respectively.
Note 9. Earnings per Share
The following tables provide a reconciliation between basic earnings per share ("EPS") and diluted EPS for the three and six months ended June 30, 2025 and 2024 (in thousands, except per share amounts):
| Three Months Ended June 30, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 · 2024 | ||||||||||
| Net Income Attributable to PRA Group, Inc. · WeightedAverageCommon Shares · EPS · Net Income Attributable to PRA Group, Inc. · WeightedAverageCommon Shares · EPS | ||||||||||
| Basic EPS | $42,374 | 39,323 | $1.08 | $21,516 | 39,364 | $0.55 | ||||
| Dilutive effect of nonvested share awards | 62 | — | 182 | (0.01) | ||||||
| Diluted EPS | $42,374 | 39,385 | $1.08 | $21,516 | 39,546 | $0.54 | ||||
| Six Months Ended June 30, | ||||||||||
| 2025 · 2024 | ||||||||||
| Net Income Attributable to PRA Group, Inc. · WeightedAverageCommon Shares · EPS · Net Loss Attributable to PRA Group, Inc. · WeightedAverageCommon Shares · EPS | ||||||||||
| Basic EPS | $46,033 | 39,436 | $1.17 | $24,991 | 39,319 | $0.64 | ||||
| Dilutive effect of nonvested share awards | 100 | — | 178 | (0.01) | ||||||
| Diluted EPS | $46,033 | 39,536 | $1.16 | $24,991 | 39,497 | $0.63 | ||||
Basic EPS are computed by dividing net income available to common stockholders of PRA Group, Inc. by weighted average common shares outstanding. Diluted EPS are computed using the same components as basic EPS, with the denominator adjusted for nonvested share awards, if dilutive. Share-based awards that are contingent upon the attainment ofperformance goals are included in the computation of diluted EPS if the effect is dilutive.
In February 2022, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to$150.0 million of its outstanding common stock. During the three months ended June 30, 2025, the Company repurchased 660,395 shares of its common stock for an aggregate cost of approximately$10.0 million at an average price of$15.14 per share. As of June 30, 2025, there was$57.7 million remaining for share repurchases under the program. The Company's practice is to retire the shares it repurchases. Repurchases are subject to restrictive covenants contained in the Company's credit facilities and the indentures that govern its senior notes.
Note 10. Income Taxes
The Company's effective tax rate for the three and six months ended June 30, 2025 and 2024 was as follows (in thousands):
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Income before income taxes | $61,128 | $33,816 | $74,504 | $47,955 |
| Income tax expense | $15,415 | $8,702 | $19,727 | $11,088 |
| Effective tax rate | 25.2% | 25.7% | 26.5% | 23.1% |
The relationship between Income before income taxes and Income tax expense for the three and six months ended June 30, 2025 and 2024 was impacted by changes in the mix of income from different taxing jurisdictions and the timing of certain discrete items.
On July 4, 2025, the One Big Beautiful Bill Act was signed into law in the U.S. The Company is evaluating the impact this law may have on its income taxes.
Note 11. Commitments and Contingencies
Forward flow agreements
The Company enters into forward flow agreements for the purchase of nonperforming loans. These agreements typically have terms ranging from six to 12 months, or they can be open-ended, and establish purchase prices and specific criteria for the accounts to be purchased. Some of the agreements establish a volume reference for the contract term in the form of a target or maximum, however, very few agreements establish a minimum contractual obligation, and many of the contracts contain early termination provisions allowing either party to cancel the agreements in accordance with a specified notice period. The amounts purchased are also dependent on actual delivery by the sellers, and while purchases under these agreements comprise a significant portion of the Company's overall purchases, as of June 30, 2025, the estimated minimum contractual purchase obligation under forward flow agreements was not significant.
Litigation and regulatory matters
The Company and its subsidiaries are from time-to-time subject to a variety of legal and regulatory claims, inquiries, proceedings, and other matters, including those described in Note 14 to the Consolidated Financial Statements in the 2024 Form 10-K. The Company accrues for potential liability arising from legal proceedings and regulatory matters when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates involve significant judgment, and accordingly, the Company's estimates will change from time-to-time, and actual expenses could exceed the current estimates. As of June 30, 2025, there were no material developments in any of the previously disclosed legal proceedings.
Note 12. Segments
The Company has determined that it is managed on a consolidated basis under a single operating segment, Accounts Receivable Management ("ARM"), and accordingly, it hasone reportable segment. The ARM segment is comprised of the Company's primary business, Debt Buying and Collection ("DBC"), which generates revenue through the purchase, collection and management of portfolios of nonperforming loans, and Claims Compensation Bureau, LLC ("CCB"), which generates revenue through the purchase of, and provision of fee-based services for, class action claims recoveries in the U.S. The chief operating decision maker ("CODM") is the Company’s chief executive officer, who assesses performance based on the Company's consolidated results prepared in accordance with GAAP.
Segment revenue, significant segment expenses and profit or loss
ARM segment revenue is presented in the Company's Consolidated Income Statements under Total revenues. Significant segment expenses regularly considered by the CODM are those most directly related to the Company's revenue generating activities, including Compensation and benefits, Legal collection costs, Legal collection fees, Agency fees, Professional and outside services and Communication. All other operating expenses appearing in the Consolidated Income Statements constitute other segment items. ARM segment profit or loss is presented in the Company's Consolidated Income Statements under Net Income/(loss) attributable to PRA Group, Inc.
Segment assets
ARM segment assets are presented in the Company's Consolidated Balance Sheets under Total assets.
Other significant segment items
Other significant segment items not presented in the Company's Consolidated Income Statements or Consolidated Balance Sheets for the three and six months ended June 30, 2025 and 2024 were as follows(in thousands):
| Three Months Ended June 30, · Six Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 · 2024 · 2025 · 2024 | ||||||
| Interest expense | $65,407 | $57,757 | $128,802 | $112,114 | ||
| Interest income | 3,046 | 2,404 | 5,471 | 4,483 | ||
| Depreciation and amortization | 2,503 | 2,637 | 5,441 | 5,357 | ||
| June 30, 2025 · December 31, 2024 | ||||||
| Equity method investment | — | 8,694 | ||||
Note 13. Recently Issued Accounting Standards
Recently issued accounting standards not yet adopted:
In December 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"), which requires enhanced annual disclosures with respect to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis, with early adoption permitted. The Company is evaluating the impact ASU 2023-09 will have on its disclosures.
In November 2024, the FASB issued ASU 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses" ("ASU 2024-03"). Subsequently, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03. ASU 2024-03 provides guidance that will expand disclosures related to the disaggregation of income statement expenses and is effective for fiscal years beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, on a retrospective or prospective basis, with early adoption permitted. The Company is evaluating the impact these ASUs will have on its disclosures.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.